Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PDE9-IN-1 is a selective and orally bioavailable Inhibitor of PDE9A(IC50 of 8.7 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 93.00 | |
5 mg | In stock | $ 228.00 | |
10 mg | In stock | $ 355.00 | |
25 mg | In stock | $ 590.00 | |
50 mg | In stock | $ 859.00 | |
100 mg | In stock | $ 1,180.00 | |
500 mg | In stock | $ 2,370.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 247.00 |
Description | PDE9-IN-1 is a selective and orally bioavailable Inhibitor of PDE9A(IC50 of 8.7 nM). |
Targets&IC50 | PDE9A:8.7 nM |
In vivo | In the Unilateral common carotid artery occlusion (UCCAO) mouse model, PDE9-IN-1 (2.5-5.0 mg/kg; orally) significantly reduces the day 6 escape latency time, increases the frequency of platform area crossings, and recoveres learning and memory function. High dose group possibly improved the escape latency time of mice[1]. |
Molecular Weight | 362.4 |
Formula | C17H23FN6O2 |
CAS No. | 2305087-92-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (124.17 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PDE9-IN-1 2305087-92-5 Metabolism PDE PDE-9-IN-1 PDE9IN1 PDE9 IN 1 inhibitor inhibit